Skip to content
FacebookTwitterLinkedinYoutubeInstagram
  • Education and Events
  • News and Updates
  • Partnerships
  • About NFID
  • Support NFID
NFID
  • Infectious Diseases
    • Column 1
      • Chickenpox (Varicella)
      • Chikungunya
      • Coronaviruses (COVID-19)
      • Dengue
      • Diphtheria
      • Ebola
      • Flu (Influenza)
      • Hepatitis
      • Hib Disease
    • Column 2
      • HIV/AIDS
      • HPV (Human Papillomavirus)
      • Japanese Encephalitis
      • Measles
      • Meningococcal Disease
      • Mpox
      • Mumps
      • Norovirus
      • Pneumococcal Disease
    • Column 3
      • Polio
      • Rabies
      • Respiratory Syncytial Virus (RSV)
      • Rotavirus
      • Rubella
      • Shingles (Herpes Zoster)
      • Tetanus
      • Tuberculosis (TB)
      • Whooping Cough (Pertussis)
      • Zika
  • Immunization
    • US Vaccine Recommendations
      • Child and Adolescent Immunization Schedule (Birth-18 Years)
      • Adult Immunization Schedule (19 Years and Older)
      • Parent-Friendly Schedule for Infants and Children (Birth-6 Years)
      • Parent-Friendly Schedule for Preteens and Teens (7-18 Years)
      • Infants/Children (Spanish)
      • Preteens/Teens (Spanish)
  • Handwashing
    • Hands In For Handwashing
  • Resources
    • Resource Library
    • En Español
    • Graphics
    • Contagious Chronicles
    • Infectious IDeas (Podcast)
    • Public Service Announcements
    • Real Stories, Real People
    • Surveys and Publications
  • Support NFID
  • Select Language

Vaccine

  1. Home
  2. Vaccine
  3. Page 12

April 13, 2021

NFID Statement on COVID-19 Vaccine Safety

FOR IMMEDIATE RELEASE Bethesda, MD (April 13, 2021)—The following statement can be attributed to William Schaffner, MD, medical director of the National Foundation for Infectious…

Learn More
March 23, 2021

NFID Releases New Communications Framework to Promote COVID-19 Prevention Measures

Guidance Reflects Expertise from Leading Healthcare, Business, Union, and Education Groups Bethesda, MD (March 23, 2021)—The National Foundation for Infectious Diseases (NFID) issued a new…

Learn More
March 4, 2021

Schaffner Report: New COVID-19 Vaccine and Other ACIP Updates

The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …

Learn More
February 28, 2021

Black History Month: Vaccine Voices for COVID-19 Vaccine Choices

As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …

Learn More
February 8, 2021

NFID Partners with Terry Bradshaw and Pfizer to Educate Adults About Pneumococcal Pneumonia and the Importance of Vaccination

Collaboration Includes PSA Featuring Terry Bradshaw to Educate Adults Age 65 Years and Older Bethesda, MD (February 8, 2021)—Today, the National Foundation for Infectious Diseases…

Learn More
February 5, 2021

The Urgent Need to Build Vaccine Confidence among US Black Adults

Only 49 percent of US Black adults plan to get a COVID-19 vaccine, and 54 percent have received or plan to get an influenza (flu) vaccine during the 2020-2021 flu season. These findings were among the results of a new survey of US Black adults conducted by NFID to better understand beliefs about COVID-19 and flu, as well as attitudes and practices around vaccination …

Learn More
February 4, 2021

New NFID Survey Underscores Need to Build Trust in COVID-19 and Flu Vaccines Among Communities of Color

Majority of US Black Adults Surveyed Are Worried about COVID-19 But Only 49 Percent Plan To Get Vaccinated Bethesda, MD (February 4, 2021)—New data released…

Learn More
January 14, 2021

The Importance of Vaccination among Hispanic Communities

NFID and the National Alliance for Hispanic Health encourage all Hispanics to receive recommended vaccines that may have been delayed during the COVID-19 pandemic …

Learn More
December 7, 2020

Now More Than Ever, It Is Important To Get Vaccinated To #FightFlu

Bethesda, MD (December 7, 2020)—As public health officials prepare for new COVID-19 vaccines, there are already vaccines available in communities across the US that can…

Learn More
November 11, 2020

Protecting Those Who Have Served on Veterans Day

As the US recognizes Veterans Day this week, the National Foundation for Infectious Diseases (NFID) and Vietnam Veterans of America (VVA) encourage veterans and their families to receive recommended vaccines that may have been delayed during the COVID-19 pandemic…

Learn More
  • « Previous
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 19
  • Next »

Subscribe to NFID Updates

Subscribe
nfid-logo@2x

7201 Wisconsin Avenue
Suite 750
Bethesda, MD 20814
Phone: 301.656.0003

NFID Facebook Profile NFID Twitter Profile NFID LinkedIn Profile NFID Youtube Account Link NFID Instagram Account

1629 K Street, NW
Suite 300
Washington, DC 20006

Founded in 1973, the National Foundation for Infectious Diseases (NFID) is an independent non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan.

This website is designed to provide education to the public and healthcare professionals about infectious diseases across the lifespan. All information on this site is for general purposes only, is based on US recommendations, and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Contact a qualified healthcare professional if you have questions or concerns about your health.

Federal EIN: 23-7198530

  • Education and Events
  • News and Updates
  • Partnerships
  • About NFID
  • Infectious Diseases
  • Immunization
  • COVID-19
  • Antibiotic Resistance
  • Resources
  • Contact Us
  • Support NFID
  • Privacy Policy
  • Accessibility
  • Disclaimer
Four-Star Rating Badge - Full Color
Platinum Transparency Seal 2023 Candid
vaccine-safety-net
Scroll To Top